Reduced-Intensity Transplant Conditioning Procedure: Clinical Trials

3 trials of Reduced-Intensity Transplant Conditioning Procedure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting, 1 terminated, 1 withdrawn. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Recruiting 1, Withdrawn 1
Phase 22Terminated 1, Withdrawn 1

Follow Reduced-Intensity Transplant Conditioning Procedure: new trials by email Literature Review of Reduced-Intensity Transplant Conditioning Procedure trials Research Report on Reduced-Intensity Transplant Conditioning Procedure

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation
Allogeneic Hematopoietic Stem Cell Transplantation, Azacitidine, Biospecimen Collection - Acute Myeloid Leukemia
Phase 1RecruitingOHSU Knight Cancer Institute402026-04-212026-10-05
Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant
anti-thymocyte globulin, donor lymphocytes, filgrastim - Leukemia, Lymphoma
Phase 2TerminatedAlliance for Clinical Trials in Oncology62010-12-012017-03-24
Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer
cyclosporine, mycophenolate mofetil, pentostatin - Chronic Myeloproliferative Disorders, Leukemia
Phase 1 / Phase 2WithdrawnUniversity of Nebraska2008-09-012023-08-14

Conditions studied

Leukemia, Myeloid, Acute (3)  ·  Congenital Abnormalities (2)  ·  Leukemia (2)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (2)  ·  Leukemia, Myelomonocytic, Chronic (2)  ·  Lymphoma (2)  ·  Lymphoma, B-Cell, Marginal Zone (2)  ·  Lymphoma, Follicular (2)  ·  Lymphoma, Mantle-Cell (2)  ·  Lymphoma, Non-Hodgkin (2)  ·  Myelodysplastic Syndromes (2)  ·  Myeloproliferative Disorders (2)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Anemia, Aplastic (1)  ·  Blast Crisis (1)

Sponsors

Alliance for Clinical Trials in Oncology (1)  ·  OHSU Knight Cancer Institute (1)  ·  University of Nebraska (1)

Countries

United States (2)

Top investigators

Asad Bashey, MD, PhD (1)  ·  Jennifer N Saultz (1)  ·  Robert Bociek, MD (1)

NIH funding

P30CA036727 (1)